COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 1373: Articles 13721-13730  | Next

Evaluation of the antibody response and adverse reactions of the BNT162b2 vaccine of participants with prior COVID-19 infection in Japan
Mitsunaga, T., Ohtaki, Y., Seki, Y., Yoshioka, M., Mori, H., Suzuka, M., Mashiko, S., Takeda, S., Mashiko, K.
10.1101/2021.07.18.21260579 — Posted: 2021-07-22
Deep Optical Blood Analysis: COVID-19 Detection as a Case Study in Next Generation Blood Screening
Cooke, C. L., Kim, K., Xu, S., Chaware, A., Yao, X., Yang, X., Neff, J., Pittman, P., McCall, C., Glass, C., Jiang, X. S., Horstmeyer, R.
10.1101/2021.07.18.21259553 — Posted: 2021-07-22
Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials
Ramachandran, R., Ross, J. S., Miller, J. E.
10.1101/2021.07.16.21260509 — Posted: 2021-07-22
Immunogenicity of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines
Naranbhai, V., Garcia-Beltran, W. F., Mairena, C. B., Thierauf, J. C., Chang, C. C., Kirkpatrick, G., Onozato, M. L., Cheng, J., St. Denis, K., Lam, E. C., Kaseke, C., Tano-Menka, R., Yang, D., Pavlovic, M., Yang, W., Kui, A., Miller, T. E., Astudillo, M. G., Cahill, J. E., Dighe, A., Gregory, D. J., Poznansky, M. C., Gaiha, G., Balazs, A. B., Iafrate, A. J.
10.1101/2021.07.18.21260732 — Posted: 2021-07-22
Virlaza Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
Brandao-Rangel, M. A. R., Melamed, D., Silva-Reis, A., Brill, B., Zamarioli, L. d. S., Oliveira, C. R., Vieira, R. P.
10.1101/2021.07.17.21260123 — Posted: 2021-07-22
An Evaluation of Liver Function Tests in SARS-CoV-2 infection in the backdrop of chronic kidney disease
Kumar, R., Jana, P., Priyadarshini, I., ROY, S., Dutta, P., Das, S.
10.1101/2021.07.16.21260406 — Posted: 2021-07-22
K-12 School Teaching Posture Correlates with COVID-19 Disease Outcomes in Ohio
Ehman, C., Luo, Y., Yang, Z., Zhu, Z., Donovan, S., Avery, A. J., Wang, J., Lawler, J., Nugent, R., Ventura, V., Lakdawala, S. S.
10.1101/2021.07.16.21260464 — Posted: 2021-07-22
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
Hasan, M. R., Kalikiri, M. K. R., Mirza, F., Sundararaju, S., Sharma, A., Lorenz, S., Chemaitelly, H., El-Kahlout, R. A., Tsui, K. M., Yassine, H. M., Coyle, P. V., Al Khal, A., Bertollini, R., Al Thani, M. H., Abu-Raddad, L. J., Tang, P.
10.1101/2021.07.18.21260718 — Posted: 2021-07-22
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants.
Sacramento, C. Q., Fintelman-Rodrigues, N., Dias, S. S. G., Temerozo, J. R., Da Silva, A. d. P. D., da Silva, C. S., Ferreira, A. C., Mattos, M., Soares, V. C., Pereira-Dutra, F., Miranda, M. D., Barreto-Vieira, D. F., da Silva, M. A. N., de Siqueira Santos, S., Torres, M., Rajoli, R. K. R., Paccanaro, A., Owen, A., Bou-Habib, D. C., Bozza, P. T., Souza, T. M. L.
10.1101/2021.07.21.451321 — Posted: 2021-07-21
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
Wang, X., Sacramento, C. Q., Jockusch, S., Chaves, O. A., Tao, C., Fintelman-Rodrigues, N., Chien, M., Temerozo, J. R., Li, X., Kumar, S., Xie, W., Patel, D. J., Meyer, C., Garzia, A., Tuschl, T., Bozza, P. T., Russo, J. J., Souza, T. M. L., Ju, J.
10.1101/2021.07.21.453274 — Posted: 2021-07-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).